SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Alkem Laboratories Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
539523 INE540L01014 848.50023 ALKEM 0.92 65,046.35 37.83 143.82 2
Quarters :
ParticularsDec 2023(Rs.Cr)Sep 2023(Rs.Cr)Jun 2023(Rs.Cr)
Gross Sales2494.592634.592253.17
Other Operating Income0.000.000.00
Other Income 95.6661.8464.70
Total Income2590.252696.432317.87
Total Expenditure 1976.641979.991919.42
PBIDT613.61716.44398.45
Interest 21.1118.7021.42
PBDT592.50697.74377.03
Depreciation58.1259.0258.11
Tax90.46111.4853.93
Fringe Benefit Tax0.000.000.00
Deferred Tax-60.31-119.27-6.45
Reported Profit After Tax504.23646.51271.44
Extra-ordinary Items -42.620.000.00
Adjusted Profit After Extra-ordinary item546.85646.51271.44
    
EPS (Unit Curr.)42.1754.0722.70
EPS (Adj) (Unit Curr.)42.1754.0722.70
Calculated EPS (Unit Curr.)42.1854.0822.71
Calculated EPS (Adj) (Unit Curr.)42.1854.0822.71
Calculated EPS (Ann.) (Unit Curr.)168.71216.3190.82
Calculated EPS (Adj) (Ann.) (Unit Curr.)168.71216.3190.82
Book Value (Unit Curr.)0.000.000.00
Dividend (%)1750.000.000.00
Equity23.9123.9123.91
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)24.6027.1917.68
PBDTM(%)23.7526.4816.73
PATM(%)20.2124.5412.05